Cell Source, Inc. Deferred Federal, State and Local, Tax Expense (Benefit)
Cell Source, Inc. (CLCS) reported Deferred Federal, State and Local, Tax Expense (Benefit) of -$1.54 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-04-15.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit · last filed 2021-04-15
- Cell Source, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2020 was -$1.54M.
- Cell Source, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2019 was -$1.42M.
- Cell Source, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2018 was -$717.00K.
- Cell Source, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2017 was -$408.00K.
| Period end | Deferred Federal, State and Local, Tax Expense (Benefit) 12 month | Deferred Federal, State and Local, Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2020-12-31 | -$1.54M 10-K · filed 2021-04-15 | |
| 2019-12-31 | -$1.42M 10-K · filed 2021-04-15 | -$1.55M 10-K · filed 2020-03-30 |
| 2018-12-31 | -$717.00K 10-K · filed 2020-03-30 | |
| 2017-12-31 | -$408.00K 10-K · filed 2019-04-01 | |
| 2016-12-31 | -$1.19M 10-K · filed 2018-07-25 | |
| 2015-12-31 | -$646.00K 10-K · filed 2018-07-25 |